Topiramate description: Difference between revisions

Revision as of 02:50, 7 February 2014

Topiramate
TOPIRAMATE^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Topiramate
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

@@ Line 6: / Line 6: @@
 ==Description==
-<!--Chemical data-->
-| C=12 | H=21 | N=1 | O=8 | S=1
-| molecular_weight = 339.363 g/mol
-| smiles = O=S(=O)(OC[C@@]21OC(O[C@H]1[C@@H]3OC(O[C@@H]3CO2)(C)C)(C)C)N
-| InChI = 1/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1
-| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
-| StdInChI = 1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1
-| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
-| StdInChIKey = KJADKKWYZYXHBB-XBWDGYHZSA-N
-}}